Comment on: Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents.
Markus SchmuggeVeneranda MattielloHeinz HengartnerNicolas von der WeidRaffaele Renellanull nullPublished in: Pediatric blood & cancer (2020)